Martin Maiers, MS, is the Vice President of Research at Be The Match BioTherapies. He and his team develop software and analytical methods used to predict factors that can impact outcomes for patients who receive an allogeneic cell therapy. Maiers has worked with many allogeneic cell therapy developers in both the early stages of therapy development and as they move through clinical trials.
Also Speaking
Zankar Desai
Assistant Technical Director, Cell Therapy Testing Lab • Dana-Farber Cancer Institute
19 November 2022
Event Info
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023